Dr. Gearóid Tuohy

Opus Genetics Inc., has announced a strategic manufacturing services agreement with National Resilience, Inc., for the development of LCA treatments

Opus Genetics Inc., a private ocular gene therapy company based in Raleigh, North Carolina, has announced a strategic manufacturing services agreement with National Resilience, Inc.… Read More »Opus Genetics Inc., has announced a strategic manufacturing services agreement with National Resilience, Inc., for the development of LCA treatments

A longitudinal natural history of RPE65-associated retinopathies in Italy showed specific genotype-phenotype characteristics

An Italian consortium of clinical researches from fourteen institutes has reported a longitudinal natural history of RPE65-assocaited retinopathies.  The report, led Dr. Francesco Testa at… Read More »A longitudinal natural history of RPE65-associated retinopathies in Italy showed specific genotype-phenotype characteristics